Centre for Infectious Diseases Research in Africa (CIDRI-Africa)
In plain English
AI plain-English summaryA new centre in Cape Town will embed cutting-edge research laboratories directly within one of the world’s highest-burden settings for HIV and tuberculosis, aiming to turn lab discoveries into better treatments faster. The problem is stark: the countries that need new drugs and vaccines for HIV and TB the most often lack the research infrastructure to develop them. Most clinical trials happen in wealthy nations, meaning treatments are tested on populations far removed from the people who will ultimately use them. CIDRI-Africa will close this gap by building shared platforms—a clinical trials unit for experimental medicine, expanded high-containment labs for handling live TB bacteria, and a data system that links patient records with lab results and population surveys. If successful, the centre will accelerate the testing of new TB drugs and HIV treatment strategies directly in the communities they are meant to serve. It will also tackle the growing overlap between infectious diseases and non-communicable conditions such as diabetes, which complicate treatment for millions on antiretroviral therapy. The work is translational, not fundamental science: its immediate goal is to shorten the path from a laboratory finding to a change in clinical practice.
View original technical description
View the original record at the funder ↗
Researchers
Related Research
Grants with similar aims, by meaning.
Original classification
Wellcome Trust CentrePlain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know